UP!

EPRS $0.14

EPRS target price
0.14
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-05-16 Downgrade Leerink Swann Outperform to Market Perform
2016-05-15 Downgrade Leerink Partner Outperform to Market Perform
2016-05-15 Downgrade Leerink Swann Outperform to Market Perform
2016-05-11 Downgrade BTIG Research Buy to Neutral
2016-05-11 Downgrade Wedbush Outperform to Neutral $11.00 to $2.00
2016-03-16 Lower Price Target BTIG Research Buy $15.00 to $10.00
2016-03-16 Lower Price Target Leerink Swann Outperform $15.00 to $10.00
2016-03-15 Reiterated Rating Wedbush Outperform $16.00 to $11.00
2016-02-09 Reiterated Rating Wedbush Outperform $16.00
2015-11-16 Reiterated Rating Wedbush Outperform $16.00
2015-05-26 Initiated Coverage BTIG Research Buy $15.00
2015-03-25 Boost Price Target Leerink Swann Outperform $10.00 to $13.00
2015-02-18 Initiated Coverage Wedbush Buy $13.00
2014-10-06 Initiated Coverage Leerink Swann Outperform $12.00
2013-11-12 Downgrade Wedbush Outperform to Neutral $1.20
2013-11-11 Downgrade Oppenheimer Outperform to Market Perform
2016-05-16 Downgrade Leerink Swann Outperform to Market Perform
2016-05-15 Downgrade Leerink Partner Outperform to Market Perform
2016-05-15 Downgrade Leerink Swann Outperform to Market Perform
2016-05-11 Downgrade BTIG Research Buy to Neutral
2016-05-11 Downgrade Wedbush Outperform to Neutral $11.00 to $2.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In EPRS 0 funds of 2220 total. Show all

Fund name Ticker shares

Major Shareholders

Name Relationship Total Shares Holding stocks
TPG Group Holdings (SBS) Advisors, Inc. 172.04%  (22239223) AERI / ALDR / CDNA / CZR / EPRS / FSL / GPK / IMS / LPLA / MGNX / NCLH / NTI / OTIC / PKY / Q / ROKA / SABR / SCAI / SUP / TIPT / TMHC / TNDM / VCYT / ZMH /
EVNIN LUKE 86.13%  (11133961) CNAT / EPRS / EPZM / ETRM / KBIO / PCRX / PIP / RDUS /
MPM BIOVENTURES III LLC 86.13%  (11133961) EPRS / PIP / RDUS /
5AM Partners III, LLC 19.72%  (2549211) BOLD / EPRS / RLYP /
ROCKLAGE SCOTT M 19.72%  (2549211) AKAO / EPRS / RLYP / RTGN /
Gallen Christopher C. EVP, Research & Development 14.26%  (1842986) EPRS /
MONTREUX EQUITY PARTNERS IV LP 12.93%  (1671400) EPRS /
Snutch Terrance P. SVP & CSO 4.66%  (602603) EPRS /
Renz Justin A SVP & CFO 1.93%  (250000) EPRS / KPTI /
Richardson Hartley T 1.54%  (199700) EPRS /
Munshi Amit Chief Executive Officer 1.37%  (177083) ARNA / EPRS / RTGN /
Hunter William L 0.85%  (110022) EPRS /
Wright C. Eugene 0.37%  (48280) EPRS /
Wyand Michael See Remarks 0.24%  (31432) EPRS /
Shea Thomas A. Chief Financial Officer 0.23%  (29970) BIOD / EPRS /
CORRIGAN MARK 0.17%  (21859) CBST / EPRS / QLTI /
Cole Jason Senior VP & General Counsel 0.12%  (15086) BLUE / EPRS /
Ticktin Robert General Counsel 0.03%  (3949) EPRS /
Vincent Aurentz Chief Business Officer 0.02%  (2200) ARNA / EPRS /